# Sandra Vukusic

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sandra-vukusic/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,491 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 72 |
| i10-index | 199 |
| Last Known Institution | Université Claude Bernard Lyon 1 |
| OpenAlex ID | https://openalex.org/A5025662371 |
| ORCID iD | https://orcid.org/0000-0001-7337-7122 |
| Works | 453 |

## Researcher papers

- [Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility](https://scholariq.org/papers/multiple-sclerosis-genomic-map-implicates-peripheral-immune-cells-and-microglia/)
- [Multiple Sclerosis Severity Score](https://scholariq.org/papers/multiple-sclerosis-severity-score/)
- [Natural History of Multiple Sclerosis with Childhood Onset](https://scholariq.org/papers/natural-history-of-multiple-sclerosis-with-childhood-onset/)
- [Myelin-oligodendrocyte glycoprotein antibody-associated disease](https://scholariq.org/papers/myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/)
- [Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis](https://scholariq.org/papers/clinical-characteristics-and-outcomes-in-patients-with-coronavirus-disease-2019/)
- [MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study](https://scholariq.org/papers/md1003-high-dose-biotin-for-the-treatment-of-progressive-multiple-sclerosis-a/)
- [Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease](https://scholariq.org/papers/clinical-features-and-risk-of-relapse-in-children-and-adults-with-myelin/)
- [Neuromyelitis optica in France](https://scholariq.org/papers/neuromyelitis-optica-in-france/)
- [Aquaporin-4 antibody–negative neuromyelitis optica](https://scholariq.org/papers/aquaporin-4-antibody-negative-neuromyelitis-optica/)
- [Cell-based therapeutic strategies for multiple sclerosis](https://scholariq.org/papers/cell-based-therapeutic-strategies-for-multiple-sclerosis/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Lyon 1 Université](https://scholariq.org/institutions/lyon-1-universite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.